Patients with atypical X-linked severe combined immunodeficiency (XSCID) may benefit from hematopoietic stem cell gene therapy.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Puck, JM; Hay, BN; Hsu, AP; Fischer, R; Tsai, E; Uzel, G; Buckley, RH; Malech, HL

Published Date

  • May 1, 2002

Published In

Volume / Issue

  • 28 / 3

Start / End Page

  • 343 - 343

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 1079-9796

Language

  • English